Immunotherapy and Targeted Therapy for Rectal Cancer Treatment

The treatment options for rectal cancer have become more personalized with the help of therapies depending on the characteristics of the tumour. Immunotherapy and targeted therapy for rectal cancer treatment make use of advanced approaches which target specific tumour-related mechanisms. Immunotherapy assists in making the immune system recognize cancer cells while targeted therapy works on blocking changes that aid in growing the cancer. The suitability of these therapies depends on tumour biology, biomarker results, stages of the cancer and treatment plan.

“Modern cancer care is heading towards personalized treatment plans. Molecular profiling of the tumour makes it easy to determine whether the patient can benefit from advanced treatment or not,” says Dr. Sandeep Nayak, a renowned surgical oncologist in Bangalore.

Dr. Sandeep Nayak is an expert in management of advanced colorectal cancers and complex treatment planning for patients with challenging conditions at MACS Clinic. His areas of expertise include accurate diagnosis, focusing on multidisciplinary decision making and personalised approaches for patients receiving rectal cancer treatment in Bangalore.

How are newer cancer treatments different from traditional approaches? Let’s explore how immunotherapy and targeted therapy work in rectal cancer care.

What Are Immunotherapy and Targeted Therapy for Rectal Cancer?

Both are newer treatment types that act on cancer more precisely than conventional treatments do.

Immunotherapy

Targeted Therapy

Unlike chemotherapy, which affects rapidly dividing cells throughout the body, these therapies are designed to act on specific cancer-related mechanisms.

Need Assistance?

Understanding your tumour profile is important for personalised cancer care. Connect with an experienced specialist to explore advanced treatment options.

Can the immune system be used to fight rectal cancer? Let’s understand how immunotherapy supports cancer treatment

How Does Immunotherapy Work in Rectal Cancer Treatment?

Our immune system naturally identifies and removes abnormal cells. Some cancer cells, though, develop mechanisms that allow them to hide from immune attack.

Immunotherapy medicines called immune checkpoint inhibitors help remove these barriers. They allow immune cells to recognise and target cancer cells more effectively.

In rectal cancer, immunotherapy may be particularly beneficial for patients whose tumours have specific characteristics, such as:



Microsatellite instability-high (MSI-H)



Deficient mismatch repair (dMMR)

Patients with these tumour features may respond better to certain immunotherapy treatments compared with patients without these markers.

How Does Targeted Therapy Work Against Rectal Cancer?

Targeted therapy focuses on specific changes that help cancer cells grow, divide or spread. Blocking those pathways can slow tumour progression.

Before suggesting it, doctors usually perform biomarker tests. These show whether the tumour has changes that a particular medicine can act on.

Targeted therapies may focus on:



Growth signals within cancer cells



Blood vessel formation that supports tumour growth



Specific genetic mutations

The suitability of targeted therapy depends on the individual tumour profile and overall treatment goals.

Are these treatments suitable for every rectal cancer patient? Let’s explore when doctors may consider these advanced options.

When Are Immunotherapy and Targeted Therapy Recommended?

Most patients don’t need these therapies. Doctors consider them when clinical picture or the tumour’s molecular features point to a real chance of benefit.

These treatments may be recommended for:



Advanced or metastatic rectal cancer



Patients whose cancers may respond poorly to standard treatments



Tumours with specific genetic or biomarker changes



Selected cases where additional treatment options are needed

A detailed evaluation helps determine whether these therapies are appropriate.

Why do doctors test tumour markers before advanced therapy? Let’s discover how biomarker testing guides personalised treatment decisions.

Role of Biomarker Testing in Selecting Advanced Rectal Cancer Treatments

Biomarker testing examines specific characteristics of cancer cells that may influence treatment response.

Important tests may include:



Mismatch Repair (MMR) and Microsatellite Instability (MSI) Testing

These tests help identify patients who may respond to immunotherapy.



RAS Mutation Testing

This helps determine whether certain targeted therapies are likely to be effective.



BRAF Testing

BRAF changes can influence treatment selection in some colorectal cancers.



HER2 Testing

HER2 status may help identify additional targeted treatment options in selected cases.

These tests allow doctors to move from a general treatment approach towards a more personalised strategy.

Can immunotherapy help every person with rectal cancer? Let’s understand which patients may be considered for this advanced treatment.

Which Rectal Cancer Patients May Benefit From Immunotherapy?

Immunotherapy is not suitable for all rectal cancer patients. Its effectiveness depends largely on the biological features of the tumour rather than cancer location alone.

Patients who may benefit from immunotherapy often include those with:



MSI-H (Microsatellite Instability-High) tumours



dMMR (Deficient Mismatch Repair) tumours



Advanced rectal cancer with specific immune-related markers

In selected patients, immunotherapy may produce a strong response because these tumours generate changes that make them more visible to the immune system.

Before recommending immunotherapy, doctors evaluate biopsy results, molecular testing reports, cancer stage, and previous treatments to determine the most appropriate approach.

How are targeted medicines selected for rectal cancer? Let’s explore the targeted treatments used based on tumour characteristics.

Which Targeted Therapies Are Used for Rectal Cancer?

Targeted therapy options depend on specific genetic changes found during biomarker testing.

Some targeted treatments used in colorectal cancer care include:



EGFR Inhibitors

These act on the epidermal growth factor receptor (EGFR) pathway and may suit selected patients with particular tumour profiles.



VEGF Inhibitors

These medicines target pathways involved in the formation of new blood vessels that supply tumour growth.



BRAF-Targeted Treatments

For patients with specific BRAF mutations, targeted medicines may be considered as part of advanced treatment strategies.



HER2-Targeted Therapy

Some tumours with HER2 alterations may respond to HER2-directed treatments.

The choice of targeted therapy depends on the tumour’s molecular profile and the overall treatment plan developed by the cancer care team.

How Are Immunotherapy and Targeted Therapy Different From Chemotherapy?

Each of the three works in its own way to control rectal cancer. The table below compares how they act and how the treatment is chosen.

Treatment	How It Works	Treatment Selection
Chemotherapy	Targets rapidly dividing cells throughout the body	Based on cancer type, stage, and treatment goals
Immunotherapy	Activates the immune system to recognise and attack cancer cells	Based on immune-related tumour markers
Targeted Therapy	Blocks specific molecules involved in cancer growth	Based on genetic and molecular changes

Chemotherapy is still a key part of rectal cancer treatment. Immunotherapy and targeted therapy simply give selected patients, whose tumours have the right features, more options.

These treatments are often used as part of a broader strategy rather than replacing standard treatments in every situation.

Can Immunotherapy Be Used Before or After Rectal Cancer Surgery?

The role of immunotherapy and targeted therapy depends on the stage and biology of rectal cancer.

In selected cases, immunotherapy may be considered before surgery, especially when tumours have specific molecular features that suggest a strong response.

After surgery, these treatments may be considered based on:



Pathology findings



Remaining cancer risk



Biomarker results



Response to previous treatments

For many patients, surgery remains an important part of curative treatment. Advanced therapies are integrated based on individual treatment requirements.

What options are available when rectal cancer spreads? Let’s understand how advanced therapies support metastatic cancer care.

Role of Immunotherapy and Targeted Therapy in Advanced Rectal Cancer

When rectal cancer spreads to distant organs, treatment goals may include controlling disease, improving symptoms, and maintaining quality of life.

In advanced rectal cancer, immunotherapy and targeted therapy may help:



Slow cancer progression



Control tumour growth



Provide additional treatment options after standard therapies



Improve outcomes for selected patients

The choice of treatment depends on the tumour’s genetics, earlier treatments, general health and the patient’s own preferences.

Why are these treatments considered an important advancement? Let’s explore the potential benefits of personalised cancer therapies

Benefits of Immunotherapy and Targeted Therapy in Rectal Cancer Care

The major advantage of immunotherapy and targeted therapy is that they are designed around the specific characteristics of cancer cells.

Potential benefits include:

However, response varies from patient to patient. Careful evaluation is necessary before choosing these therapies.

Are advanced therapies free from side effects? Let’s understand what patients may experience during treatment.

Possible Side Effects and Management During Treatment

They work differently from chemotherapy, but they can still cause side effects.

Possible Immunotherapy Side Effects

Because immunotherapy activates the immune system, it may sometimes cause immune-related reactions such as:

Possible Targeted Therapy Side Effects

These vary with the medicine used, and may include:

With regular monitoring, doctors can catch these early and deal with them.

How Doctors Monitor Response to Immunotherapy and Targeted Therapy

Monitoring helps doctors understand how the cancer is responding and whether treatment adjustments are needed.

Evaluation may include:

Regular follow-up allows treatment to remain aligned with the patient’s condition.

Can advanced therapies work alongside other treatments? Let’s explore how different treatments are combined for better cancer care.

Combining Advanced Therapies With Other Rectal Cancer Treatments

Rectal cancer treatment often involves multiple approaches working together. Depending on the stage and characteristics of the cancer, immunotherapy or targeted therapy may be combined with:



Surgery



Chemotherapy



Radiation therapy



Supportive care

A multidisciplinary approach ensures that every aspect of treatment is considered, from cancer control to recovery and quality of life.

Dr. Sandeep Nayak provides comprehensive colorectal cancer management through detailed assessment, personalised treatment strategies, and advanced care options for patients receiving rectal cancer treatment in Bangalore at MACS Clinic. His approach ensures that treatment decisions are tailored according to each patient’s tumour characteristics and individual needs.

Need Assistance?

Every rectal cancer case requires a personalised treatment plan. Get in touch with an expert to understand available therapies based on your cancer characteristics.

FAQ

What is immunotherapy for rectal cancer?

Immunotherapy is a treatment that helps the immune system recognise and attack cancer cells. It may benefit selected rectal cancer patients with specific tumour markers.

How does targeted therapy treat rectal cancer?

It blocks certain molecules or pathways that cancer cells need to grow and survive.

Is immunotherapy suitable for all rectal cancer patients?

No. It depends on the tumour, mainly on biomarkers such as MSI-H or dMMR.

What tests are needed before starting targeted therapy?

Biomarker tests such as RAS, BRAF, HER2, and other molecular tests may be performed to guide treatment selection.

Can immunotherapy replace surgery or chemotherapy for rectal cancer?

Not always. Surgery and chemotherapy remain important treatments, while immunotherapy may be used for selected patients.

What are the side effects of targeted therapy?

They depend on the medicine. Skin changes, tiredness, diarrhoea and blood pressure changes are some that may occur.

How long does immunotherapy treatment continue for rectal cancer?

The duration depends on treatment response, cancer status, and the individual treatment plan.

Disclaimer: The information shared in this content is for educational purposes and not for promotional use.